Device typeCancer antigen 125 (CA125) IVD, kit, chemiluminescent immunoassay: A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of cancer antigen 125 (CA125), a marker commonly associated with ovarian cancer, in a clinical specimen using a chemiluminescent immunoassay method.
FDA categoryOvarian adnexal mass assessment score test system
Device ID00380740146269
Catalog number03R7521
AvailabilityPrescription
MRI safetyLabeling does not contain MRI Safety Information